Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.14 trillion and total revenue of $111.55 billion.
Market Cap
1.14T
Revenue
111.55B
Profits
-39.41B
PE Ratio
n/a
Profit Margin
-35.33%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 106.08B | -2.92% | 1,099,706 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.27B | -1.23% | 245,665 | 14.92B |
| 3 | ARGX | argenx SE | 49.79B | -2.46% | 148,103 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.93B | 0.38% | 300,518 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.60B | -1.28% | 63,825 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.39B | -2.30% | 697,079 | - |
| 7 | INSM | Insmed Incorporated | 30.00B | -0.74% | 532,867 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.97B | 0.70% | 1,310,626 | 2.38B |
| 9 | BNTX | BioNTech SE | 24.26B | -3.43% | 844,426 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.18B | -0.60% | 862,316 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.30B | -0.56% | 305,264 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.20B | -3.00% | 2,536,454 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.42B | 0.41% | 401,574 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.87B | -1.87% | 105,829 | 845.52M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.44B | 2.00% | 2,880,162 | - |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.25B | -1.91% | 1,184,376 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.96B | 1.17% | 496,336 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.39B | -0.62% | 313,488 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 11.51B | - | 480,942 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -3.67% | 190,358 | 958.40M |
| 21 | EXEL | Exelixis, Inc. | 11.22B | -0.02% | 1,740,429 | 2.32B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.35B | -3.41% | 1,630,654 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.34B | -3.38% | 670,373 | 1.09B |
| 24 | CYTK | Cytokinetics, Incorporated | 9.61B | 17.14% | 12,804,587 | 88.04M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.27B | 4.94% | 930,233 | 5.37M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.08B | -3.44% | 204,546 | 7.46M |
| 27 | TECH | Bio-Techne Corporation | 8.77B | 2.45% | 1,101,271 | 1.22B |
| 28 | KRYS | Krystal Biotech, Inc. | 8.41B | -0.64% | 231,002 | 417.30M |
| 29 | PCVX | Vaxcyte, Inc. | 8.08B | -4.31% | 894,943 | - |
| 30 | NUVL | Nuvalent, Inc. | 7.89B | -2.22% | 244,600 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.88B | 3.02% | 755,657 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.85B | 2.29% | 5,958,599 | 113.29M |
| 33 | CELC | Celcuity Inc. | 6.77B | -3.37% | 977,518 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.69B | -2.74% | 195,574 | 51.48M |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.51B | 0.93% | 626,001 | 521.31M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.23B | 6.63% | 1,344,462 | 217.17M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.23B | -1.97% | 173,185 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.20B | -1.17% | 753,061 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.18B | -0.98% | 135,709 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.15% | 426,763 | 15.00M |
| 41 | SYRE | Spyre Therapeutics, Inc. | 6.12B | 2.66% | 788,448 | - |
| 42 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | - | - | - |
| 43 | BLTE | Belite Bio, Inc | 6.08B | 0.08% | 34,813 | - |
| 44 | CGON | CG Oncology, Inc. | 5.86B | -1.64% | 419,336 | 4.04M |
| 45 | IMVT | Immunovant, Inc. | 5.55B | -2.08% | 445,146 | - |
| 46 | CORT | Corcept Therapeutics Incorporated | 5.51B | -0.48% | 389,667 | 769.10M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.51B | -0.73% | 823,114 | 7.50M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.44B | -1.87% | 164,201 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.35B | -1.45% | 321,628 | 1.73B |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.04% | 1,977,076 | 1.00B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.21B | -1.39% | 625,397 | 812.03M |
| 52 | LEGN | Legend Biotech Corporation | 5.20B | 6.15% | 5,020,333 | 1.03B |
| 53 | TGTX | TG Therapeutics, Inc. | 5.16B | -2.11% | 645,116 | 616.29M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.88B | -5.43% | 1,839,395 | 4.10M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.80B | -1.25% | 164,023 | 2.04M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.60B | 0.54% | 45,848 | 268.09M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.20B | -2.74% | 353,338 | 7.70M |
| 58 | MANE | Veradermics, Incorporated | 4.19B | 6.61% | 566,091 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.15B | 22.64% | 3,081,813 | - |
| 60 | TVTX | Travere Therapeutics, Inc. | 4.00B | -3.61% | 2,083,807 | 536.20M |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.95B | -0.69% | 752,968 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.79B | -0.23% | 379,623 | 1.07B |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.75B | -0.67% | 52,599 | 803.79M |
| 64 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.65B | 3.35% | 1,394,555 | 588.99M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.56B | -3.56% | 1,220,136 | - |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.36B | -2.14% | 374,034 | 22.50M |
| 67 | ALMS | Alumis Inc. | 3.24B | 0.95% | 468,322 | 24.05M |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.23B | -1.32% | 903,643 | 62.38M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.18B | -2.92% | 371,078 | 247.00M |
| 70 | KLRA | Kailera Therapeutics, Inc. | 3.15B | -2.99% | 194,077 | - |
| 71 | ERAS | Erasca, Inc. | 3.06B | -2.86% | 2,082,586 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 2.93B | -4.05% | 348,533 | - |
| 73 | DNLI | Denali Therapeutics Inc. | 2.92B | -1.29% | 1,372,964 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.90B | -1.36% | 373,480 | 376.07M |
| 75 | BEAM | Beam Therapeutics Inc. | 2.88B | -4.59% | 1,163,435 | 139.74M |
| 76 | NKTR | Nektar Therapeutics | 2.83B | -3.40% | 288,028 | 55.23M |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.81B | -3.95% | 474,447 | - |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | 0.23% | 144,494 | 451.36M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.02% | 1,058,726 | 190.41M |
| 80 | KOD | Kodiak Sciences Inc. | 2.68B | 2.32% | 277,457 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.59B | 0.58% | 278,650 | 1.55M |
| 82 | IMNM | Immunome, Inc. | 2.56B | -3.11% | 281,806 | 6.94M |
| 83 | IRON | Disc Medicine, Inc. | 2.56B | -0.94% | 83,618 | - |
| 84 | IDYA | IDEAYA Biosciences, Inc. | 2.46B | -3.01% | 218,637 | 225.27M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.46B | -1.08% | 186,730 | - |
| 86 | VERA | Vera Therapeutics, Inc. | 2.45B | -3.94% | 421,534 | - |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.42B | -2.44% | 889,749 | 15.36M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | -0.97% | 501,762 | 673.00M |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.40B | 1.24% | 526,846 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -2.97% | 297,569 | - |
| 91 | ZLAB | Zai Lab Limited | 2.35B | -1.46% | 94,968 | 460.16M |
| 92 | ADMA | ADMA Biologics, Inc. | 2.34B | -2.13% | 2,519,141 | 510.17M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.23B | -4.26% | 762,626 | 2.20B |
| 94 | ADPT | Adaptive Biotechnologies Corporation | 2.20B | -5.10% | 1,065,079 | 276.98M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.76% | 514,947 | 283.06M |
| 96 | MESO | Mesoblast Limited | 2.03B | -2.00% | 39,282 | 65.38M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.02B | -4.91% | 1,900,295 | 52.04M |
| 98 | TRVI | Trevi Therapeutics, Inc. | 2.02B | 0.28% | 368,268 | - |
| 99 | AAPG | Ascentage Pharma Group International | 2.01B | 0.14% | 306 | 82.08M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.01B | -5.71% | 144,454 | 184.42M |
| 101 | ANAB | AnaptysBio, Inc. | 2.00B | -0.10% | 217,125 | 234.60M |
| 102 | TYRA | Tyra Biosciences, Inc. | 1.97B | -5.63% | 208,467 | - |
| 103 | PHVS | Pharvaris N.V. | 1.96B | -0.17% | 353,929 | - |
| 104 | ZYME | Zymeworks Inc. | 1.95B | -1.05% | 186,542 | 105.97M |
| 105 | GENB | Generate Biomedicines, Inc. | 1.95B | 5.88% | 129,481 | 31.89M |
| 106 | TSHA | Taysha Gene Therapies, Inc. | 1.89B | -0.90% | 637,535 | 9.77M |
| 107 | VRDN | Viridian Therapeutics, Inc. | 1.88B | 30.01% | 11,369,351 | 70.92M |
| 108 | HRMY | Harmony Biosciences Holdings, Inc. | 1.88B | -0.15% | 235,435 | 868.45M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.87B | -3.28% | 375,489 | 11.13M |
| 110 | GLPG | Galapagos NV | 1.87B | -0.67% | 46,146 | 1.31B |
| 111 | INBX | Inhibrx Biosciences, Inc. | 1.86B | -0.38% | 194,799 | 1.30M |
| 112 | VCEL | Vericel Corporation | 1.86B | 0.18% | 174,847 | 276.26M |
| 113 | NTLA | Intellia Therapeutics, Inc. | 1.85B | -4.33% | 2,745,573 | 67.67M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.85B | 1.36% | 207,492 | - |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -1.12% | 102,713 | - |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -5.26% | 7,276,982 | 74.68M |
| 117 | ARDX | Ardelyx, Inc. | 1.73B | -3.90% | 2,936,479 | 427.68M |
| 118 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | -2.05% | 649,556 | 217.17M |
| 119 | INVA | Innoviva, Inc. | 1.68B | -1.09% | 208,007 | 411.33M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.68B | -4.22% | 831,734 | 71.78M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.67B | -1.41% | 55,095 | - |
| 122 | OCS | Oculis Holding AG | 1.65B | -1.59% | 313,763 | 1.51M |
| 123 | NUVB | Nuvation Bio Inc. | 1.63B | 6.35% | 7,602,931 | 143.05M |
| 124 | IOVA | Iovance Biotherapeutics, Inc. | 1.61B | 1.30% | 12,672,017 | 263.50M |
| 125 | AGIO | Agios Pharmaceuticals, Inc. | 1.61B | -2.00% | 288,739 | 66.05M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.60B | -2.46% | 343,693 | 68.56M |
| 127 | PGEN | Precigen, Inc. | 1.52B | 3.62% | 2,668,701 | 9.68M |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.51B | -3.55% | 58,373 | - |
| 129 | GLUE | Monte Rosa Therapeutics, Inc. | 1.51B | -3.73% | 214,732 | 123.67M |
| 130 | NBTX | Nanobiotix S.A. | 1.50B | 9.42% | 67,253 | 38.27M |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.47B | -1.32% | 196,600 | - |
| 132 | IMTX | Immatics N.V. | 1.47B | -1.57% | 263,514 | 56.67M |
| 133 | ATAI | AtaiBeckley Inc. | 1.46B | -5.36% | 2,087,701 | 4.09M |
| 134 | FTRE | Fortrea Holdings Inc. | 1.46B | 25.63% | 2,037,606 | 2.71B |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.45B | -2.90% | 309,635 | 2.50M |
| 136 | IMCR | Immunocore Holdings plc | 1.43B | -1.46% | 80,201 | 400.02M |
| 137 | ABCL | AbCellera Biologics Inc. | 1.39B | -0.33% | 10,531,134 | 75.13M |
| 138 | BHVN | Biohaven Ltd. | 1.38B | -9.37% | 2,682,858 | - |
| 139 | MBX | MBX Biosciences, Inc. | 1.38B | -1.72% | 132,102 | - |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.15% | 2,868,357 | 73.62M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.36B | -5.62% | 1,703,259 | 71.80M |
| 142 | GHRS | GH Research PLC | 1.32B | -1.71% | 66,833 | - |
| 143 | QURE | uniQure N.V. | 1.32B | 1.21% | 816,538 | 16.10M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -3.32% | 186,594 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.29B | -4.00% | 369,396 | - |
| 146 | NVAX | Novavax, Inc. | 1.29B | -2.24% | 1,687,083 | 1.12B |
| 147 | SVRA | Savara Inc. | 1.29B | -4.15% | 360,515 | - |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.28B | -1.57% | 92,713 | - |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.25B | -2.26% | 391,002 | - |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.22B | -3.02% | 259,690 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.22B | 0.45% | 123,813 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.21B | -5.80% | 154,345 | 10.00M |
| 153 | AVLN | Avalyn Pharma Inc. | 1.18B | -2.79% | 209,771 | - |
| 154 | DBVT | DBV Technologies S.A. | 1.16B | 1.87% | 105,767 | 5.74M |
| 155 | PHAR | Pharming Group N.V. | 1.16B | -0.37% | 1,127 | 376.13M |
| 156 | URGN | UroGen Pharma Ltd. | 1.12B | -0.90% | 249,394 | 109.79M |
| 157 | EYPT | EyePoint, Inc. | 1.12B | -3.54% | 413,545 | 31.37M |
| 158 | COAG | Hemab Therapeutics Holdings, Inc. | 1.09B | -2.84% | 257,759 | - |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | -1.81% | 679,182 | 291.85M |
| 160 | OMER | Omeros Corporation | 1.06B | -1.61% | 411,540 | - |
| 161 | IVA | Inventiva S.A. | 1.05B | 3.42% | 221,958 | 7.94M |
| 162 | SEPN | Septerna, Inc. | 1.05B | -5.52% | 144,395 | 45.95M |
| 163 | AKTS | Aktis Oncology, Inc. | 1.04B | -1.32% | 53,256 | 6.50M |
| 164 | GERN | Geron Corporation | 1.01B | 0.32% | 7,770,099 | 183.88M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 979.79M | 0.13% | 523,068 | 185.74M |
| 166 | PHAT | Phathom Pharmaceuticals, Inc. | 974.61M | -4.66% | 545,506 | 204.89M |
| 167 | SANA | Sana Biotechnology, Inc. | 949.05M | 0.29% | 806,595 | - |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 948.74M | -4.83% | 751,690 | - |
| 169 | LBRX | LB Pharmaceuticals Inc | 946.01M | 3.64% | 59,769 | - |
| 170 | XNCR | Xencor, Inc. | 928.82M | -6.21% | 273,054 | 125.58M |
| 171 | ANNX | Annexon, Inc. | 921.42M | -0.35% | 561,078 | - |
| 172 | SLS | SELLAS Life Sciences Group, Inc. | 904.21M | -2.39% | 1,734,227 | - |
| 173 | MGTX | MeiraGTx Holdings plc | 895.95M | -0.21% | 225,500 | 81.39M |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 886.72M | 1.13% | 616,264 | 84.28M |
| 175 | CTMX | CytomX Therapeutics, Inc. | 884.93M | -2.75% | 1,037,749 | 76.20M |
| 176 | ANRO | Alto Neuroscience, Inc. | 879.82M | -0.36% | 134,857 | - |
| 177 | MNKD | MannKind Corporation | 878.52M | 1.25% | 1,577,372 | 348.97M |
| 178 | SPTX | Seaport Therapeutics, Inc. | 874.96M | -2.94% | 449,777 | - |
| 179 | EVMN | Evommune, Inc. | 864.08M | 1.52% | 528,987 | 13.00M |
| 180 | CGEM | Cullinan Therapeutics, Inc. | 862.50M | -7.11% | 471,739 | - |
| 181 | JANX | Janux Therapeutics, Inc. | 858.94M | -2.08% | 392,461 | 10.00M |
| 182 | TBPH | Theravance Biopharma, Inc. | 858.90M | -1.36% | 119,062 | 107.46M |
| 183 | ABUS | Arbutus Biopharma Corporation | 857.67M | -0.80% | 168,042 | 14.08M |
| 184 | ABSI | Absci Corporation | 836.31M | -4.27% | 3,926,669 | 2.80M |
| 185 | DSGN | Design Therapeutics, Inc. | 834.74M | 1.48% | 241,179 | - |
| 186 | SGP | SpyGlass Pharma, Inc. | 824.80M | 1.09% | 51,732 | - |
| 187 | VOR | Vor Biopharma Inc. | 823.08M | 3.26% | 440,777 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 809.25M | 1.01% | 118,648 | - |
| 189 | KURA | Kura Oncology, Inc. | 802.41M | -2.27% | 327,911 | 67.48M |
| 190 | RLMD | Relmada Therapeutics, Inc. | 764.64M | -1.62% | 192,874 | - |
| 191 | GYRE | Gyre Therapeutics, Inc. | 754.13M | -1.83% | 29,960 | 116.59M |
| 192 | TENX | Tenax Therapeutics, Inc. | 744.81M | -5.03% | 141,022 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 741.27M | -4.65% | 2,834,802 | 22.00K |
| 194 | TRAX | First Tracks Biotherapeutics, Inc. | 726.60M | 1.75% | 162,581 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 675.77M | -0.31% | 870,213 | 49.80M |
| 196 | SLDB | Solid Biosciences Inc. | 669.21M | -5.95% | 559,349 | - |
| 197 | FBRX | Forte Biosciences, Inc. | 661.89M | -5.16% | 60,739 | - |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 661.87M | -2.25% | 83,229 | - |
| 199 | ARVN | Arvinas, Inc. | 658.80M | -4.45% | 373,526 | 262.60M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 648.04M | 2.43% | 576,941 | 7.83M |
| 201 | DRTS | Alpha Tau Medical Ltd. | 643.35M | -2.92% | 575,296 | - |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 621.30M | 4.58% | 496,115 | 106.47M |
| 203 | STRO | Sutro Biopharma, Inc. | 610.61M | -4.00% | 103,433 | 102.48M |
| 204 | CRMD | CorMedix Inc. | 605.46M | -2.28% | 417,888 | 311.71M |
| 205 | PRME | Prime Medicine, Inc. | 596.97M | -2.88% | 1,253,069 | 4.63M |
| 206 | AURA | Aura Biosciences, Inc. | 596.09M | 11.20% | 1,857,959 | - |
| 207 | ANL | Adlai Nortye Ltd. | 591.40M | -1.24% | 171,636 | 5.00M |
| 208 | AGMB | AgomAb Therapeutics NV | 589.50M | -1.12% | 36,789 | - |
| 209 | ALT | Altimmune, Inc. | 588.42M | 0.33% | 2,195,235 | 41.00K |
| 210 | PRTA | Prothena Corporation plc | 587.32M | 1.11% | 142,272 | 9.68M |
| 211 | TRDA | Entrada Therapeutics, Inc. | 572.16M | -0.82% | 218,678 | 25.42M |
| 212 | PROK | ProKidney Corp. | 566.18M | -0.27% | 289,473 | 893.00K |
| 213 | CBIO | Crescent Biopharma, Inc. | 565.89M | -4.97% | 143,185 | 11.88M |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 564.61M | -2.12% | 857,560 | 170.16M |
| 215 | CADL | Candel Therapeutics, Inc. | 559.24M | 1.39% | 1,793,440 | - |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 547.80M | 0.56% | 388,684 | - |
| 217 | EIKN | Eikon Therapeutics, Inc. | 547.34M | -1.56% | 69,017 | - |
| 218 | RIGL | Rigel Pharmaceuticals, Inc. | 544.40M | -0.28% | 72,421 | 294.28M |
| 219 | TECX | Tectonic Therapeutic, Inc. | 544.16M | -2.63% | 53,847 | - |
| 220 | MDXG | MiMedx Group, Inc. | 542.16M | 0.83% | 577,198 | 389.42M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 528.30M | - | 58,801 | - |
| 222 | ENGN | enGene Therapeutics Inc. | 525.20M | 3.02% | 210,539 | - |
| 223 | VSTM | Verastem, Inc. | 514.76M | -1.51% | 448,468 | 30.91M |
| 224 | VALN | Valneva SE | 509.41M | 3.68% | 4,143 | 205.07M |
| 225 | OCGN | Ocugen, Inc. | 506.08M | -19.19% | 22,660,738 | 4.41M |
| 226 | OVID | Ovid Therapeutics Inc. | 503.54M | -0.68% | 1,178,543 | 7.25M |
| 227 | CLYM | Climb Bio, Inc. | 496.32M | 7.22% | 865,986 | - |
| 228 | STTK | Shattuck Labs, Inc. | 495.82M | -5.20% | 243,104 | 1.00M |
| 229 | XOMA | XOMA Royalty Corporation | 493.07M | 0.83% | 89,948 | 52.15M |
| 230 | FDMT | 4D Molecular Therapeutics, Inc. | 487.03M | 1.06% | 253,327 | 85.21M |
| 231 | UPB | Upstream Bio, Inc. | 486.24M | -4.03% | 123,765 | 2.85M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 481.65M | 1.05% | 146,765 | 12.14M |
| 233 | LYEL | Lyell Immunopharma, Inc. | 474.12M | -1.93% | 25,348 | 36.00K |
| 234 | ZURA | Zura Bio Limited | 473.45M | -6.20% | 277,006 | - |
| 235 | IMMX | Immix Biopharma, Inc. | 473.40M | -5.80% | 449,949 | - |
| 236 | SGMT | Sagimet Biosciences Inc. | 470.55M | -3.54% | 792,274 | - |
| 237 | RGNX | REGENXBIO Inc. | 464.04M | -4.26% | 175,853 | 170.44M |
| 238 | ADCT | ADC Therapeutics SA | 463.61M | -0.95% | 1,223,181 | 79.18M |
| 239 | PRTC | PureTech Health plc | 460.34M | -0.76% | 21,359 | 4.66M |
| 240 | FULC | Fulcrum Therapeutics, Inc. | 459.44M | -1.78% | 218,860 | 80.00M |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.69M | -4.31% | 120,400 | - |
| 242 | ASMB | Assembly Biosciences, Inc. | 454.37M | 2.77% | 153,335 | 72.30M |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 445.60M | -1.98% | 396,213 | 216.11M |
| 244 | AVIR | Atea Pharmaceuticals, Inc. | 443.38M | -2.37% | 84,588 | - |
| 245 | CABA | Cabaletta Bio, Inc. | 438.61M | 2.87% | 6,401,853 | - |
| 246 | AUTL | Autolus Therapeutics plc | 431.15M | 3.18% | 1,050,207 | 75.39M |
| 247 | NGNE | Neurogene Inc. | 431.15M | -2.16% | 41,414 | 925.00K |
| 248 | LXEO | Lexeo Therapeutics, Inc. | 428.22M | -0.34% | 139,446 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 423.10M | 0.28% | 41,345 | 66.98M |
| 250 | LRMR | Larimar Therapeutics, Inc. | 416.05M | -5.09% | 530,441 | - |
| 251 | AVTX | Avalo Therapeutics, Inc. | 414.07M | 12.48% | 324,475 | 59.00K |
| 252 | NMRA | Neumora Therapeutics, Inc. | 409.22M | -3.03% | 343,976 | - |
| 253 | IPSC | Century Therapeutics, Inc. | 406.70M | -1.53% | 260,239 | 109.16M |
| 254 | BNTC | Benitec Biopharma Inc. | 399.58M | -4.23% | 98,621 | - |
| 255 | VTVT | vTv Therapeutics Inc. | 397.10M | -1.54% | 16,494 | 17.00K |
| 256 | IVVD | Invivyd, Inc. | 390.27M | -6.12% | 1,708,676 | 53.43M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 383.20M | -2.77% | 638,651 | - |
| 258 | NAGE | Niagen Bioscience, Inc. | 382.78M | -3.25% | 488,693 | 129.42M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 380.04M | -0.71% | 179,083 | 35.11M |
| 260 | IRD | Opus Genetics, Inc. | 377.01M | 1.15% | 323,063 | 14.20M |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 369.89M | 4.58% | 606,982 | 14.56M |
| 262 | SRZN | Surrozen, Inc. | 366.20M | -0.59% | 51,162 | 3.48M |
| 263 | PBYI | Puma Biotechnology, Inc. | 365.29M | -4.65% | 213,604 | 228.37M |
| 264 | NAUT | Nautilus Biotechnology, Inc. | 364.72M | -0.69% | 195,285 | - |
| 265 | YDES | YD Bio Limited | 361.80M | 2.49% | 5,376 | 510.36K |
| 266 | MNPR | Monopar Therapeutics Inc. | 357.69M | -2.18% | 40,029 | - |
| 267 | ARMP | Armata Pharmaceuticals, Inc. | 349.89M | -3.20% | 65,665 | 4.90M |
| 268 | CMPX | Compass Therapeutics, Inc. | 347.57M | -0.52% | 3,713,408 | 850.00K |
| 269 | RZLT | Rezolute, Inc. | 341.22M | -0.45% | 698,708 | - |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 338.38M | 3.80% | 51,011 | - |
| 271 | PALI | Palisade Bio, Inc. | 338.20M | -5.16% | 2,678,227 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 337.38M | -2.02% | 168,367 | 63.50M |
| 273 | IMRX | Immuneering Corporation | 335.13M | -3.81% | 358,762 | - |
| 274 | SLN | Silence Therapeutics plc | 326.86M | -5.08% | 50,165 | 559.00K |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 326.42M | -1.29% | 272,519 | 1.00 |
| 276 | ABEO | Abeona Therapeutics Inc. | 325.65M | -3.78% | 680,625 | 5.82M |
| 277 | AVXL | Anavex Life Sciences Corp. | 309.52M | -2.05% | 234,892 | - |
| 278 | GLSI | Greenwich LifeSciences, Inc. | 304.66M | 0.05% | 86,790 | - |
| 279 | ACIU | AC Immune SA | 300.58M | -0.66% | 169,341 | 4.62M |
| 280 | NGEN | NervGen Pharma Corp. | 298.63M | 0.82% | 121,143 | - |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 297.20M | 4.75% | 401,795 | 26.87M |
| 282 | TARA | Protara Therapeutics, Inc. | 290.97M | -1.28% | 247,740 | - |
| 283 | EDIT | Editas Medicine, Inc. | 289.70M | -1.33% | 806,172 | 38.69M |
| 284 | LENZ | LENZ Therapeutics, Inc. | 284.70M | -2.16% | 364,450 | 19.09M |
| 285 | ELDN | Eledon Pharmaceuticals, Inc. | 283.73M | -1.19% | 420,460 | - |
| 286 | NBP | NovaBridge Biosciences | 282.76M | 1.87% | 785,080 | - |
| 287 | CCCC | C4 Therapeutics, Inc. | 282.00M | -4.78% | 716,232 | 35.95M |
| 288 | ALEC | Alector, Inc. | 281.98M | 1.79% | 178,222 | 21.05M |
| 289 | FHTX | Foghorn Therapeutics Inc. | 273.54M | -0.43% | 38,075 | 30.91M |
| 290 | NERV | Minerva Neurosciences, Inc. | 270.07M | -2.69% | 68,022 | - |
| 291 | CHRS | Coherus Oncology, Inc. | 269.88M | 1.16% | 498,155 | 42.17M |
| 292 | CLLS | Cellectis S.A. | 268.35M | 0.81% | 2,855 | 79.59M |
| 293 | HELP | Cybin Inc. | 262.44M | -0.85% | 266,937 | - |
| 294 | ARTV | Artiva Biotherapeutics, Inc. | 262.04M | -6.10% | 112,679 | 251.00K |
| 295 | FATE | Fate Therapeutics, Inc. | 261.63M | 25.00% | 7,009,527 | 6.65M |
| 296 | CGEN | Compugen Ltd. | 260.97M | 4.55% | 263,949 | 72.76M |
| 297 | NVCT | Nuvectis Pharma, Inc. | 254.55M | 3.49% | 110,796 | - |
| 298 | ALXO | ALX Oncology Holdings Inc. | 254.32M | 0.53% | 356,187 | - |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 252.04M | -0.77% | 22,608 | 19.39M |
| 300 | SABS | SAB Biotherapeutics, Inc. | 250.88M | -3.25% | 192,146 | 114.70K |
| 301 | CDXS | Codexis, Inc. | 243.53M | 6.77% | 949,216 | 70.39M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 235.91M | -3.15% | 214,079 | 82.03M |
| 303 | ACHV | Achieve Life Sciences, Inc. | 235.85M | 0.91% | 288,635 | - |
| 304 | ADAG | Adagene Inc. | 234.89M | -2.87% | 19,454 | 7.67M |
| 305 | OBIO | Orchestra BioMed Holdings, Inc. | 234.38M | -0.37% | 120,943 | 33.48M |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 231.33M | 0.90% | 35,220 | 44.64M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 230.58M | -0.79% | 762,122 | 1.55M |
| 308 | VYGR | Voyager Therapeutics, Inc. | 228.86M | -1.03% | 236,077 | 40.37M |
| 309 | HRTX | Heron Therapeutics, Inc. | 228.25M | -0.82% | 897,351 | 154.90M |
| 310 | KROS | Keros Therapeutics, Inc. | 226.97M | -2.05% | 185,617 | 244.06M |
| 311 | MDWD | MediWound Ltd. | 222.92M | 0.49% | 41,037 | 16.96M |
| 312 | PLYX | Polaryx Therapeutics, Inc. | 219.67M | -9.38% | 78,137 | - |
| 313 | CNTX | Context Therapeutics Inc. | 217.29M | 2.83% | 365,000 | - |
| 314 | REPL | Replimune Group, Inc. | 213.86M | -14.52% | 4,666,375 | - |
| 315 | NKTX | Nkarta, Inc. | 211.73M | -1.66% | 441,930 | - |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 208.30M | -0.65% | 117,988 | 146.07M |
| 317 | ENLV | Enlivex Ltd. | 203.40M | -0.99% | 110,616 | - |
| 318 | UNCY | Unicycive Therapeutics, Inc. | 202.91M | 0.75% | 667,459 | - |
| 319 | RNAC | Cartesian Therapeutics, Inc. | 202.73M | -0.43% | 172,164 | 1.78M |
| 320 | RNA | Atrium Therapeutics, Inc. | 201.23M | 0.78% | 50,383 | 18.62M |
| 321 | CAMP | Camp4 Therapeutics Corporation | 199.40M | -0.52% | 41,704 | 3.50M |
| 322 | HUMA | Humacyte, Inc. | 198.97M | -3.09% | 2,476,158 | 2.04M |
| 323 | MGNX | MacroGenics, Inc. | 198.94M | -2.19% | 294,206 | 149.50M |
| 324 | WHWK | Whitehawk Therapeutics, Inc. | 198.93M | 1.32% | 54,776 | 7.15M |
| 325 | OABI | OmniAb, Inc. | 198.35M | -2.84% | 141,234 | 18.67M |
| 326 | ELTX | Elicio Therapeutics, Inc. | 192.79M | -2.69% | 64,121 | - |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 187.65M | 1.38% | 155,209 | 13.11M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 186.94M | 0.19% | 140,524 | - |
| 329 | CRBU | Caribou Biosciences, Inc. | 186.20M | -0.79% | 620,332 | 11.16M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 182.50M | 2.88% | 97,871 | - |
| 331 | OKUR | OnKure Therapeutics, Inc. | 182.18M | -1.96% | 66,659 | - |
| 332 | DTIL | Precision BioSciences, Inc. | 179.85M | -8.65% | 188,697 | 34.26M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 179.49M | 0.20% | 125,487 | - |
| 334 | KRRO | Korro Bio, Inc. | 179.42M | -4.53% | 66,329 | 6.39M |
| 335 | CNTN | Canton Strategic Holdings, Inc. | 179.03M | - | 149,344 | - |
| 336 | ANTX | AN2 Therapeutics, Inc. | 174.22M | -0.21% | 177,457 | - |
| 337 | PRQR | ProQR Therapeutics N.V. | 167.52M | -3.05% | 244,993 | 19.19M |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 166.78M | -2.82% | 794,017 | 52.74M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 164.92M | -3.80% | 2,025,898 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 160.37M | 0.89% | 73,504 | 2.00M |
| 341 | BDTX | Black Diamond Therapeutics, Inc. | 159.84M | 3.33% | 606,562 | 70.00M |
| 342 | SPRB | Spruce Biosciences, Inc. | 159.22M | -0.76% | 15,261 | 697.00K |
| 343 | AGEN | Agenus Inc. | 158.97M | 2.99% | 582,386 | 114.20M |
| 344 | MOLN | Molecular Partners AG | 158.15M | -0.49% | 5,720 | 856.30K |
| 345 | MENS | Jyong Biotech Ltd. | 156.88M | -3.32% | 90,173 | - |
| 346 | IMUX | Immunic, Inc. | 150.69M | 4.33% | 151,994 | - |
| 347 | ALPS | Alps Group Inc | 149.76M | -2.07% | 2,004 | 3.74M |
| 348 | KZIA | Kazia Therapeutics Limited | 149.52M | 1.91% | 62,724 | 1.27M |
| 349 | IFRX | InflaRx N.V. | 148.56M | -3.52% | 585,301 | 34.44K |
| 350 | GALT | Galectin Therapeutics Inc. | 146.14M | -3.06% | 226,675 | - |
| 351 | SPRO | Spero Therapeutics, Inc. | 143.28M | -1.00% | 321,887 | 66.80M |
| 352 | HURA | TuHURA Biosciences, Inc. | 142.42M | 4.67% | 387,986 | - |
| 353 | CNTB | Connect Biopharma Holdings Limited | 140.17M | - | 76,524 | 64.00K |
| 354 | EDSA | Edesa Biotech, Inc. | 139.42M | -2.61% | 194,292 | - |
| 355 | IPHA | Innate Pharma S.A. | 136.77M | 8.38% | 23,976 | 10.57M |
| 356 | ACOG | Alpha Cognition Inc. | 135.98M | 3.22% | 15,070 | 10.22M |
| 357 | EQ | Equillium, Inc. | 130.25M | -1.90% | 77,976 | 4.39M |
| 358 | PEPG | PepGen Inc. | 127.52M | 2.50% | 522,811 | - |
| 359 | NTHI | NeOnc Technologies Holdings, Inc. | 125.95M | 20.77% | 339,203 | 39.99K |
| 360 | KLRS | Kalaris Therapeutics, Inc. | 122.32M | -3.80% | 66,648 | - |
| 361 | GNLX | Genelux Corporation | 122.25M | -3.33% | 32,130 | 8.00K |
| 362 | PYXS | Pyxis Oncology, Inc. | 118.75M | 7.39% | 579,186 | 13.86M |
| 363 | VRCA | Verrica Pharmaceuticals Inc. | 118.37M | 8.34% | 26,027 | 35.58M |
| 364 | CBUS | Cibus, Inc. | 117.09M | 3.02% | 269,436 | 3.64M |
| 365 | AARD | Aardvark Therapeutics, Inc. | 114.32M | -0.57% | 56,634 | - |
| 366 | TTRX | Turn Therapeutics Inc. | 110.22M | -0.27% | 5,095 | - |
| 367 | CRDF | Cardiff Oncology, Inc. | 109.73M | -2.73% | 553,128 | 593.00K |
| 368 | CGTX | Cognition Therapeutics, Inc. | 109.01M | -4.69% | 528,907 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 108.45M | 1.35% | 732,757 | - |
| 370 | GUTS | Fractyl Health, Inc. | 108.29M | -6.12% | 1,394,678 | 3.00K |
| 371 | CUE | Cue Biopharma, Inc. | 108.11M | 11.26% | 389,166 | 27.47M |
| 372 | VANI | Vivani Medical, Inc. | 106.23M | -6.34% | 190,163 | - |
| 373 | SEER | Seer, Inc. | 104.94M | -4.62% | 705,416 | 16.58M |
| 374 | ONCY | Oncolytics Biotech Inc. | 103.10M | -4.29% | 1,101,602 | - |
| 375 | NRXS | NeurAxis, Inc. | 102.63M | 7.47% | 242,747 | 3.57M |
| 376 | KALA | KALA BIO, Inc. | 102.34M | 1.94% | 1,249,525 | - |
| 377 | NRXP | NRx Pharmaceuticals, Inc. | 101.75M | 2.67% | 948,598 | 1.23M |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 100.74M | 3.09% | 665,981 | - |
| 379 | PMN | ProMIS Neurosciences, Inc. | 99.00M | -0.27% | 25,013 | - |
| 380 | ANIX | Anixa Biosciences, Inc. | 98.24M | -4.25% | 85,547 | - |
| 381 | COYA | Coya Therapeutics, Inc. | 98.05M | -1.88% | 133,408 | 7.95M |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 94.64M | 1.32% | 670,366 | 65.34K |
| 383 | ACET | Adicet Bio, Inc. | 92.58M | 1.92% | 77,674 | - |
| 384 | RANI | Rani Therapeutics Holdings, Inc. | 89.87M | -3.41% | 379,130 | 1.63M |
| 385 | LONA | LeonaBio, Inc. | 89.24M | -0.52% | 11,903 | - |
| 386 | PTHS | Pelthos Therapeutics Inc. | 88.27M | 5.99% | 3,708 | 16.80M |
| 387 | PYPD | PolyPid Ltd. | 86.64M | 1.34% | 14,409 | - |
| 388 | OKYO | OKYO Pharma Limited | 85.55M | -2.96% | 26,083 | - |
| 389 | EXOZ | eXoZymes, Inc. | 83.09M | -1.21% | 387 | -700.00 |
| 390 | MAIA | MAIA Biotechnology, Inc. | 82.51M | -2.16% | 305,312 | - |
| 391 | ATYR | aTyr Pharma, Inc. | 81.32M | -1.60% | 359,362 | 190.00K |
| 392 | CSBR | Champions Oncology, Inc. | 81.31M | -0.59% | 1,333 | 57.95M |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 80.78M | -3.92% | 356,237 | - |
| 394 | ICCC | ImmuCell Corporation | 79.97M | 1.38% | 10,241 | 27.64M |
| 395 | GANX | Gain Therapeutics, Inc. | 79.00M | -1.57% | 335,942 | - |
| 396 | GOSS | Gossamer Bio, Inc. | 78.98M | -3.97% | 2,317,900 | 48.47M |
| 397 | ANVS | Annovis Bio, Inc. | 78.73M | - | 1,305,569 | - |
| 398 | ATHE | Alterity Therapeutics Limited | 78.21M | 1.77% | 9,557 | 4.43M |
| 399 | XBIT | XBiotech Inc. | 78.05M | 0.40% | 8,486 | - |
| 400 | FBIO | Fortress Biotech, Inc. | 76.96M | 0.42% | 126,034 | 63.26M |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 74.93M | 0.36% | 113,355 | - |
| 402 | PLRX | Pliant Therapeutics, Inc. | 74.30M | 0.84% | 149,144 | - |
| 403 | QTTB | Q32 Bio Inc. | 74.17M | 0.60% | 98,285 | 53.74M |
| 404 | RLYB | Rallybio Corporation | 74.16M | -0.71% | 293,297 | 858.00K |
| 405 | TCRX | TScan Therapeutics, Inc. | 72.72M | -0.82% | 325,083 | 10.33M |
| 406 | OSTX | OS Therapies Incorporated | 71.47M | 2.41% | 185,734 | - |
| 407 | ACTU | Actuate Therapeutics, Inc. | 70.19M | 0.34% | 16,461 | - |
| 408 | MNOV | MediciNova, Inc. | 69.89M | 1.43% | 6,031 | 409.66K |
| 409 | MCRB | Seres Therapeutics, Inc. | 68.54M | -7.02% | 75,090 | 789.00K |
| 410 | IBO | Impact BioMedical Inc. | 68.36M | -0.22% | 33,846 | 32.00K |
| 411 | FLNA | Filana Therapeutics, Inc. | 66.18M | -2.14% | 397,773 | - |
| 412 | IMMP | Immutep Limited | 63.42M | -1.32% | 1,074,530 | 5.28M |
| 413 | IMA | ImageneBio, Inc. | 62.86M | -1.66% | 6,065 | 800.00K |
| 414 | ESLA | Estrella Immunopharma, Inc. | 61.98M | -5.06% | 10,003 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 60.62M | -1.57% | 111,025 | 20.70M |
| 416 | BYSI | BeyondSpring Inc. | 59.21M | -4.64% | 24,691 | 1.88M |
| 417 | CING | Cingulate Inc. | 58.84M | -3.62% | 137,347 | - |
| 418 | PDSB | PDS Biotechnology Corporation | 58.26M | 4.38% | 325,632 | - |
| 419 | INKT | MiNK Therapeutics, Inc. | 57.78M | 0.30% | 9,856 | - |
| 420 | IBIO | iBio, Inc. | 56.56M | -0.95% | 488,928 | 300.00K |
| 421 | KZR | Kezar Life Sciences, Inc. | 54.30M | -0.54% | 25,535 | - |
| 422 | TIL | Instil Bio, Inc. | 54.19M | 1.91% | 14,943 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 52.86M | -0.35% | 36,526 | 25.21M |
| 424 | HYPD | Hyperion DeFi, Inc. | 52.80M | 3.00% | 203,080 | 813.46K |
| 425 | ENTX | Entera Bio Ltd. | 52.68M | 1.80% | 107,951 | 42.00K |
| 426 | DARE | Daré Bioscience, Inc. | 48.76M | 7.68% | 1,988,238 | 1.03M |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 48.43M | 2.84% | 31,089 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 48.30M | - | 27,730 | 10.86M |
| 429 | LIXT | Lixte Biotechnology Holdings, Inc. | 48.21M | 26.14% | 130,729 | - |
| 430 | NTRB | Nutriband Inc. | 48.02M | 6.76% | 26,727 | 2.04M |
| 431 | ATOS | Atossa Therapeutics, Inc. | 47.36M | -6.14% | 167,537 | - |
| 432 | XLO | Xilio Therapeutics, Inc. | 45.68M | -5.16% | 17,760 | 43.77M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 45.21M | -0.38% | 88,396 | - |
| 434 | MREO | Mereo BioPharma Group plc | 43.99M | -4.01% | 574,162 | 500.00K |
| 435 | PSTV | Plus Therapeutics, Inc. | 43.40M | 0.40% | 67,955 | 5.21M |
| 436 | LITS | Lite Strategy, Inc. | 41.63M | 0.44% | 137,205 | - |
| 437 | RNXT | RenovoRx, Inc. | 41.27M | 3.49% | 209,264 | 1.12M |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 40.18M | -3.28% | 27,086 | 120.77M |
| 439 | ALGS | Aligos Therapeutics, Inc. | 39.91M | 0.16% | 49,734 | 2.19M |
| 440 | INMB | INmune Bio Inc. | 39.48M | 0.34% | 226,293 | 50.00K |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 39.28M | 5.00% | 111,673 | 90.00K |
| 442 | PTN | Palatin Technologies, Inc. | 38.88M | 0.80% | 10,929 | 8.96M |
| 443 | EVAX | Evaxion A/S | 38.78M | 1.75% | 8,826 | 7.53M |
| 444 | VERU | Veru Inc. | 36.27M | 0.44% | 39,217 | 16.89M |
| 445 | GRCE | Grace Therapeutics, Inc. | 35.67M | -2.33% | 230,350 | - |
| 446 | NXTC | NextCure, Inc. | 35.14M | 9.19% | 13,198 | - |
| 447 | PLUR | Pluri Inc. | 34.98M | 3.04% | 7,000 | 1.34M |
| 448 | SNSE | Sensei Biotherapeutics, Inc. | 34.84M | -2.64% | 20,025 | - |
| 449 | CRVO | CervoMed Inc. | 34.72M | 1.35% | 8,883 | 4.01M |
| 450 | APLM | Apollomics, Inc. | 34.50M | -4.59% | 956 | 8.84M |
| 451 | BOLD | Boundless Bio, Inc. | 34.40M | -2.23% | 17,829 | - |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 33.05M | -1.45% | 206,673 | 1.14M |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 33.02M | -0.56% | 18,576 | - |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 32.17M | 2.25% | 108,817 | - |
| 455 | IGC | IGC Pharma, Inc. | 31.59M | -0.40% | 223,975 | 1.11M |
| 456 | TVGN | Tevogen Bio Holdings Inc. | 31.04M | 0.60% | 6,634 | - |
| 457 | SKYE | Skye Bioscience, Inc. | 30.45M | -0.37% | 86,932 | - |
| 458 | QNTM | Quantum BioPharma Ltd. | 30.42M | 0.38% | 186,490 | - |
| 459 | NNVC | NanoViricides, Inc. | 30.23M | -6.67% | 320,216 | - |
| 460 | LSTA | Lisata Therapeutics, Inc. | 29.85M | -1.36% | 6,489 | 170.00K |
| 461 | TPST | Tempest Therapeutics, Inc. | 29.84M | -1.42% | 56,423 | - |
| 462 | SNTI | Senti Biosciences Holdings, Inc. | 29.72M | 1.23% | 37,934 | 22.00K |
| 463 | BCTX | BriaCell Therapeutics Corp. | 29.52M | -1.96% | 29,344 | - |
| 464 | KYNB | Kyntra Bio, Inc. | 29.33M | 0.62% | 1,862 | 6.44M |
| 465 | RNTX | Rein Therapeutics Inc. | 28.88M | 0.98% | 1,562,446 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 28.58M | 0.20% | 18,626 | 14.99M |
| 467 | DYAI | Dyadic International, Inc. | 28.41M | 3.82% | 11,881 | 3.09M |
| 468 | PLRZ | Polyrizon Ltd. | 27.40M | -4.94% | 19,928 | - |
| 469 | CELU | Celularity Inc. | 27.40M | -3.47% | 64,397 | 26.55M |
| 470 | SER | Serina Therapeutics, Inc. | 26.97M | -4.72% | 23,549 | 130.00K |
| 471 | JSPR | Jasper Therapeutics, Inc. | 26.76M | -3.02% | 106,899 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 26.55M | 2.36% | 15,403 | 14.97M |
| 473 | ABVC | ABVC BioPharma, Inc. | 25.45M | -1.90% | 62,600 | 797.92K |
| 474 | OTLK | Outlook Therapeutics, Inc. | 25.44M | -7.35% | 3,429,758 | 205.70K |
| 475 | LGVN | Longeveron Inc. | 25.04M | -0.90% | 145,233 | 1.20M |
| 476 | MRKR | Marker Therapeutics, Inc. | 24.34M | -6.41% | 69,347 | 3.55M |
| 477 | LTRN | Lantern Pharma Inc. | 24.32M | -2.69% | 165,559 | - |
| 478 | AEON | AEON Biopharma, Inc. | 24.09M | 0.21% | 5,626 | - |
| 479 | VTGN | Vistagen Therapeutics, Inc. | 23.93M | -2.96% | 153,312 | 789.00K |
| 480 | CRIS | Curis, Inc. | 23.55M | 1.43% | 82,122 | 9.44M |
| 481 | VYNE | VYNE Therapeutics Inc. | 22.10M | 1.11% | 374,617 | 570.00K |
| 482 | ALLR | Allarity Therapeutics, Inc. | 21.80M | 12.80% | 249,725 | 320.00K |
| 483 | XCUR | Exicure, Inc. | 21.67M | 4.62% | 17,131 | 500.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 21.24M | 0.58% | 269,958 | - |
| 485 | CVKD | Cadrenal Therapeutics, Inc. | 19.73M | -3.03% | 72,573 | - |
| 486 | QNCX | Quince Therapeutics, Inc. | 19.64M | -1.23% | 938,679 | - |
| 487 | COCP | Cocrystal Pharma, Inc. | 19.35M | 7.14% | 103,209 | - |
| 488 | LPCN | Lipocine Inc. | 18.78M | 2.18% | 69,938 | 1.98M |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 18.51M | -3.86% | 311,243 | 3.94M |
| 490 | OSRH | OSR Holdings, Inc. | 17.85M | -7.17% | 1,941,573 | 2.91M |
| 491 | ICU | SeaStar Medical Holding Corporation | 17.47M | 1.04% | 22,729 | 1.23M |
| 492 | LEXX | Lexaria Bioscience Corp. | 17.06M | 2.47% | 63,505 | 368.00K |
| 493 | TOVX | Theriva Biologics, Inc. | 16.99M | -2.50% | 1,713,094 | - |
| 494 | NCEL | NewcelX Ltd. | 16.32M | -5.29% | 29,266 | - |
| 495 | INAB | IN8bio, Inc. | 16.05M | 1.24% | 10,078 | - |
| 496 | TRAW | Traws Pharma, Inc. | 15.74M | 2.65% | 31,947 | 2.79M |
| 497 | GRDX | GridAI Technologies Corp. | 15.62M | 3.70% | 37,592 | - |
| 498 | GNTA | Genenta Science S.p.A. | 15.33M | -6.08% | 59,780 | - |
| 499 | CLRB | Cellectar Biosciences, Inc. | 15.26M | 27.21% | 51,555,799 | - |
| 500 | HIND | Vyome Holdings, Inc. | 14.96M | 2.02% | 27,936 | 319.71K |